Medical expert Jiang Lin developed affordable anti-cancer drug NY45, but was framed by his apprentice Huang Xing and his young boss Li Baoqiang, who was fired and embezzled the results. He discovered that the drug had fatal risks and tried his best to stop it but was humiliated. At the critical moment, the chairman of Fu Group extended a helping hand. Jiang Lin put forward the condition that he must first recall the problematic drugs and treat the patients. With Fu's support, he successfully resolved the crisis and brought the culprit to justice. After that, Jiang Lin joined Fu and led the team to develop LR77, a safer broad-spectrum anti-cancer drug priced at only 50 yuan per shot, realizing his lifelong dream of making the disease affordable to ordinary families.
